ResearcherTaiho Pharmaceutical (Japan)No recent work listed

Hiroto S. Fukushima

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-0736-3680; OpenAlex author ID A5032047277. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2016: 1 paper

Papers 1

ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the motility and proliferative activity of th… Co-author DOI 10.1186/s12943-016-0516-4 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yoshinobu Okabe · 1 shared paper, 2016 · strength 0.05
- Paper ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the m… DOI 10.1186/s12943-016-0516-4 ↗
Yoshiki Naito · 1 shared paper, 2016 · strength 0.05
- Paper ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the m… DOI 10.1186/s12943-016-0516-4 ↗
Yuhei Kitasato · 1 shared paper, 2016 · strength 0.05
- Paper ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the m… DOI 10.1186/s12943-016-0516-4 ↗
Yusuke Ishida · 1 shared paper, 2016 · strength 0.05
- Paper ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the m… DOI 10.1186/s12943-016-0516-4 ↗
Hiroyuki Horiuchi · 1 shared paper, 2016 · strength 0.05
- Paper ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the m… DOI 10.1186/s12943-016-0516-4 ↗
Hirohisa Yano · 1 shared paper, 2016 · strength 0.05
- Paper ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the m… DOI 10.1186/s12943-016-0516-4 ↗
Jun Akiba · 1 shared paper, 2016 · strength 0.05
- Paper ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the m… DOI 10.1186/s12943-016-0516-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.